This figure corresponds to the Average Price over the previous 50/200 days.
For ImmunoGen stocks, the 50-day moving average is the support level today.
For ImmunoGen stocks, the 200-day moving average is the support level today.
Are you interested in ImmunoGen, Inc. stocks and want to buy them, or are they already in your portfolio?
If yes, then on this page you will find useful information about the dynamics of the ImmunoGen
stock price in 2023, 2024, 2025, 2026, 2027.
How much will one ImmunoGen share be worth in
2023 - 2027?
When should I take profit in ImmunoGen stock?
When should I record a loss on ImmunoGen stock?
What are analysts' forecasts for ImmunoGen stock?
What is the future of ImmunoGen stock?
We forecast ImmunoGen stock performance using neural networks based on historical data on ImmunoGen stocks.
Also, when forecasting, technical analysis tools are used, world geopolitical and news factors are taken into account.
ImmunoGen stock prediction results are shown below and presented in the form of graphs, tables and text information, divided into time intervals.
(Next month, 2023, 2024, 2025, 2026 and 2027)
The final quotes of the instrument at the close of the previous trading day are a signal to adjust the forecasts for ImmunoGen shares. This happens once a day.
Historical and forecast chart of ImmunoGen stock
The chart below shows the historical price of ImmunoGen stock and a prediction chart for the next month.
For convenience, prices are divided by color. Forecast prices include: Optimistic Forecast, Pessimistic Forecast,
and Weighted Average Best Forecast. Detailed values for the ImmunoGen stock price can be found in the table below.
Long-term forecasts by years.
ImmunoGen daily forecast for a month
Date
Target
Pes.
Opt.
Vol., %
Jun 10
14.55
14.46
14.82
2.45
Jun 11
14.49
14.41
14.76
2.45
Jun 12
14.32
14.10
14.54
3.13
Jun 13
14.04
13.87
14.25
2.77
Jun 14
14.28
14.14
14.36
1.58
Jun 15
14.40
14.14
14.63
3.51
Jun 16
14.36
14.12
14.58
3.30
Jun 17
14.51
14.26
14.71
3.14
Jun 18
14.72
14.60
14.95
2.46
Jun 19
14.63
14.41
14.81
2.83
Jun 20
14.66
14.57
14.91
2.29
Jun 21
14.89
14.70
15.05
2.37
Jun 22
14.83
14.60
14.90
2.08
Jun 23
14.98
14.91
15.10
1.27
Jun 24
14.84
14.64
15.07
2.94
Jun 25
15.00
14.78
15.27
3.34
Jun 26
14.99
14.83
15.23
2.70
Jun 27
15.18
14.91
15.37
3.14
Jun 28
15.17
15.05
15.44
2.62
Jun 29
14.89
14.79
15.00
1.44
Jun 30
14.78
14.59
15.00
2.84
Jul 01
14.44
14.34
14.55
1.41
Jul 02
14.51
14.32
14.60
1.96
Jul 03
14.36
14.11
14.56
3.23
Jul 04
14.37
14.24
14.63
2.71
Jul 05
14.66
14.39
14.86
3.23
Jul 06
14.69
14.51
14.87
2.49
Jul 07
14.54
14.38
14.74
2.44
Jul 08
14.52
14.31
14.69
2.61
Jul 09
14.69
14.55
14.78
1.60
ImmunoGen Daily Price Targets
ImmunoGen Stock Forecast 06-10-2023.
Forecast target price for 06-10-2023: $14.55. Negative dynamics for ImmunoGen shares will prevail with possible volatility of 2.395%. Pessimistic target level: 14.46 Optimistic target level: 14.82
ImmunoGen Stock Forecast 06-11-2023.
Forecast target price for 06-11-2023: $14.49. Negative dynamics for ImmunoGen shares will prevail with possible volatility of 2.394%. Pessimistic target level: 14.41 Optimistic target level: 14.76
ImmunoGen Stock Forecast 06-12-2023.
Forecast target price for 06-12-2023: $14.32. Negative dynamics for ImmunoGen shares will prevail with possible volatility of 3.036%. Pessimistic target level: 14.10 Optimistic target level: 14.54
ImmunoGen Stock Forecast 06-13-2023.
Forecast target price for 06-13-2023: $14.04. Negative dynamics for ImmunoGen shares will prevail with possible volatility of 2.697%. Pessimistic target level: 13.87 Optimistic target level: 14.25
ImmunoGen Stock Forecast 06-14-2023.
Forecast target price for 06-14-2023: $14.28. Positive dynamics for ImmunoGen shares will prevail with possible volatility of 1.555%. Pessimistic target level: 14.14 Optimistic target level: 14.36
ImmunoGen Stock Forecast 06-15-2023.
Forecast target price for 06-15-2023: $14.40. Positive dynamics for ImmunoGen shares will prevail with possible volatility of 3.395%. Pessimistic target level: 14.14 Optimistic target level: 14.63
ImmunoGen, Inc., a clinical-stage biotechnology company, is developing antibody-drug conjugate (ADC) therapies for cancer. Its candidate products include mirvetuximab soravtansine, an alpha-folate receptor-targeted ADC that is in phase III clinical trials for the treatment of platinum-resistant ovarian cancer; and IMGN632, an ADC targeting CD123, which is in phase I clinical trials for the treatment of AML and blast plasmacytoid dendritic cell neoplasms.
ImmunoGen Address
830 WINTER ST, WALTHAM, MA, US
Market Capitalization:
3 248 626 000 $
Market capitalization is the total market value of all issued shares of a company. It is calculated by the formula
multiplying the number of shares in the company outstanding by the market price of one share.
EBITDA:
-238 676 000 $
EBITDA is earnings before interest, income tax and depreciation of assets.
PE Ratio:
None
P/E ratio (price to earnings) - shows the ratio between the price of a share and the company's profit
PEG Ratio:
N/A
Price/earnings to growth
DPS:
N/A
Dividend Per Share is a financial indicator equal to the ratio of the company's net profit available for distribution to the annual average of ordinary shares.
DY:
N/A
Dividend yield is a ratio that shows how much a company pays in dividends each year at the stock price.
EPS:
-0.99
EPS shows how much of the net profit is accounted for by the common share.
Quarterly Earnings Growth YOY:
4.078
Quarterly Revenue Growth YOY:
0.31
Trailing PE:
-
Trailing P/E depends on what has already been done. It uses the current share price and divides it by the total earnings per share for the last 12 months.
Forward PE:
-
Forward P/E uses projections of future earnings instead of final numbers.
EV To Revenue:
8.87
Enterprise Value (EV) /Revenue
EV To EBITDA:
-4.372
The EV / EBITDA ratio shows the ratio of the cost (EV) to its profit before tax, interest and amortization (EBITDA).
Shares Outstanding:
226070000
Number of issued ordinary shares
Shares Float:
N/A
Number of freely tradable shares
Shares Short Prior Month:
N/A
Shares Short Prior Month - the number of shares in short positions in the last month.
All forecast data on the site are provided for informational purposes of using neural forecasting tools in the financial market and are not a call to action and,
moreover, are not trading signals.
When using the forecast data, the investor assumes all financial risks. The pandaforecast.com portal is not responsible for the loss of your money in the stock market
as a result of using the information contained on the site.
This website uses cookies to ensure you get the best experience on our website